Development of a Simple Isocratic HPLC-UV Method for the Simultaneous Analysis of Repaglinide and Metformin Hydrochloride in Nanoemulsion Formulations and Commercial Tablets

M. Cetin and S. Sahin, Drug Deliv., 23(8), 2796 – 2805 (2016).

N. T. Shurrab and E-S. A. Arafa, Obes. Med., 17, 100186 (2020).

Y. W. Wang, S. J. He, X. Feng, et al., Drug Des. Devel. Ther., 11, 2421 – 2429 (2017).

F. Khonsari, P. Zakeri-Milani, and M. Jelvehgari, Iran J. Pharm. Res., 13(1), 67 – 80 (2014).

S. K. Chinnaiyan, D. Karthikeyani and V. R. Gadela, Pharm. Nanotechnol., 6(4), 253 – 263 (2018).

J. Wang, D. Chin, C. Poon, et al., J. Control Release, 329, 1198 – 1209 (2021).

J. Akhtar, H. H. Siddiqui, Badruddeen, Curr. Drug Deliv., 11(2), 243 – 252 (2014).

EMA: Repaglinide. Available from: https://www.ema.europa.eu/en/documents/product-information/repaglinideaccord-epar-product-informationen.pdf.

L. J. Scott, Drugs, 72(2), 249 – 272 (2012).

X. D. Yang, W. S. Li, Y. J. Tian, et al., Trop. J. Pharm. Res., 15(6), 1123 – 1128 (2016).

J. Akhtar, H. H. Siddiqui, S. Fareed, et al., Drug Deliv., 23(6), 2026 – 2034 (2016).

M. K. Rawat, A. Jain, and S. Singh, J. Pharma Sci, 100(6), 2406 – 2417 (2011).

J. Xie, N. Li, X. Jiang, et al., Diabetes Metab. Syndr. Obes,, 12, 519 – 526 (2019).

Z. Zhu, T. Yang T, Y. Zhao, et al., Asian J. Pharm. Sci., 9(4), 218 – 225 (2014).

EMA: Metformin hydrochloride. Available from: https://www.ema.europa.eu/en/documents/referral/metformin-article-31-referral-annex-ien.pdf.

FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Available from: https://www.accessdata.fda.gov/scripts/cder/ob/searchproduct.cfm.

TÝTCK-Türkiye Ýlaç ve Týbbi Cihaz Kurumu. Available from: https: // www.titck.gov.tr/kubkt

N. S. Abdelhamid, M. T. Elsaady, N. W. Ali, et al., Anal. Chem. Lett., 9(3), 418 – 429 (2019).

K. B. Ahir, E. M. Patelia, and A. Shah, J. Chromatogr. Sep. Tech., 4(1), 1000166 (2013).

S. Aslan and B. Yýlmaz, Am. J. Anal. Chem., 8, 541 – 552 (2017).

M. M. Fouad and N. S. Rashed, JGTPS, 5(3), 1844 – 1848 (2014).

D. S. Jahnavi, D. V. N. Rao, and Y. R. Reddy, GJRA, 5(10), 8 – 11 (2016).

S. S. Joshi, R. R. Nahire, N. R. Shastri, et al., Acta Chromatogr., 24(3), 419 – 432 (2012).

M. A. Mahrouse and N. T. Lamie, Microchem. J., 147, 691 – 706 (2019).

D. R. Patel, L. J. Patel, and M. M. Patel, Asian J. Res. Chem., 4(3), 500 – 505 (2011).

V. G. Prasanth, S. Cicy Eapen, P. Velekkat, et al., Am. J. Pharm. Health, 8(6), 16 – 31 (2020).

L. K. Soni, T. Narsinghani, and M. Jain, J. Liq. Chromatogr. Relat. Technol., 35(3), 385 – 392 (2012).

K. Sonia, K. Manikandan, and M. Nappinnai, et al., Int. J. Pharm. Qual. Assur., 7(3), 46 – 50 (2016).

R. Tatiparthi, D. Duraiswamy, and C. Kothapalli, FABAD J. Pharm. Sci., 35, 69 – 75 (2010).

International Conference on Harmonization (ICH). ICH Guidelines Q2 (R1). Validation of Analytical Procedures: Text and Methodology. Available from: http://www.ema.europa.eu/docs/enGB/documentlibrary/Scientificguideline/2009/09/WC500002662.pdf.

E. Sigward, N. Mignet, P. Rat, et al., Int. J. Nanomed., 8(1), 611 – 625 (2013).

M. Çelebier, T. Reçber, E. Koçak, et al., Braz. J. Pharm. Sci., 49(2), 359 – 366 (2013).

A. Gumieniczek, A. Berecka-Rycerz, T. Mroczek, et al., Molecules, 24(24), 4430 (2019).

M. T. da Trindade, A. C. Kogawa, and H. R. N. Salgado, Crit. Rev. Anal. Chem., 48(1), 66 – 72 (2018).

H. A. Mowafy, F. K. Alanazi, and G. M. El Maghraby, Saudi Pharm. J., 20(1), 29 – 34 (2012).

International Conference on Harmonization (ICH). Harmonized Tripartite Guideline: Stability Testing of New Drug Substances and Products: Q1A (R2), The Steering Committee: Geneva (2003). Available from: https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf.

N. Osel, T. Planinšek Parfant, A. Kristl, et al., Pharmaceutics, 13(7), 1065 (2021).

G. A. Shabir, J. Chromatogr. A, 987(1 – 2), 57 – 66 (2003).